Perspective on Risk Score 363
I n this issue of Circulation: Heart Failure, "Preoperative Assessment of High-Risk Candidates to Predict Survival After Heart Transplantation" 1 presents a sophisticated statistical analysis of multiple pretransplantation factors that influence postoperative survival in 711 regular and 111 alternate list cardiac recipients transplanted between 1999 and 2010. They found that increasing donor age is associated with increasing recipient mortality. They previously looked at ischemic time 2 and found an age-related tolerance to ischemia with better tolerance in younger donor hearts.
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The application of the CARRS scoring model, using 5 pretransplant risk factors (C for prior CVA, A for albumin <3.5 mg/dL, R for retransplant, R for glomerular filtration rate <40 mL/min, and S for >2 prior sternotomies with 2 points for each, except renal with 1 point) sorted out high and low survival groups. For low-scoring (<3) CARRS patients in the alternate (high risk) group, there was no difference from the regular group in 1-and 5-year survivals (1 year: 87% and 5 years: ≈70%), but the CARRS ≥3 alternate recipients survival was 52.9% at 1 year. In their patients on the alternate list with a CARRS score of >4 the 1-year survival rate was <20%. Finally, the application of this scoring to >12 000 United Network for Organ Sharing (UNOS) database patients found a significant difference in survival between groups using a cutoff point of CARRS <3.
The patients in the study had already been selected. The CARRS score sorted out the high-risk patients. This scoring system using 5 factors seems to be a powerful addition, but can we distill the selection process or, as it currently stands, the postselection process down to 5 factors based on a single center study? We know that every center has selection biases.
When they examined predictors of outcome by univariate and multivariate analyses, retransplantation and prior stroke were significant by multivariate analysis. This raises some controversy because retransplantation has not been so obvious a risk in other reports, including our own. 3 We know retransplantation carries the same risk as primary transplantation in stable elective patients who are >6 months post transplantation and that it is high risk in acute graft failure in close proximity to the transplant. The number of retransplants and the specifics of their timing are not mentioned in this study. My guess is that in many programs, it would not be associated with poor outcome.
Prior stroke can mean many things. Clearly, the older patient may have had intracerebral bleeding, arteriosclerosis, or embolism from chronic atrial fibrillation that is quite a bit different from the young adult congenital heart patient with an embolic event. The degree of central nervous system damage, the amount of neurological residual, and the central nervous system event-free interval may also be important. Is it possible that the sample of stroke patients in this study is biased toward the older more complex patients?
The >2 sternotomies criterion can also be challenged because the degree of difficulty may be as variable as the time from the last sternotomy, history of mediastinal pathology, and the quality and maturity of adhesions that are found. The younger adult congenital group and the older acquired coronary disease and valvular pathology groups may have different risks. One wonders if there was a bias toward older patients in this series.
We know from risk calculations for left ventricular assist device insertion that 1 or 2 weeks of intensive medical therapy can change the preimplantation risk score drastically. With the CARRS system, raising the serum albumin and the glomerular filtration rate could happen during a short time period. The score could change during the time on the waiting list.
Although the significant survival difference found with the UNOS validation is impressive, it does not eliminate the possibility that there are many other significant factors that also would separate higher and lower survival UNOS groups.
Finally, having a high-risk alternate group and low-risk regular list have always been controversial and better suited to larger programs. Definitions become so important, yet ages and other characteristics overlap and the groups of potential recipients and of high-risk donors are difficult to sort out. High risk at 1 center might be the norm at another. It may be thought of as helpful to some, but of no value to others. In this article, 13.5% of the patients were high risk primarily by virtue of their age, but the mean age of the high-risk group was only 63 years. My guess is that in most programs, 63 years would not be considered high risk. Similar controversies extend into donor selection. Much of this study is focused on preselected high-and low-risk groups as defined by the single institutional criteria.
The authors used the CARRS score in a retrospective study of patients that had been selected and transplanted using standard criteria. Looking back on standard selection provides a long checklist of obvious factors that are used in every transplant program.
Our current selection criteria come from clinical practice and from data in the International Society for Heart and Lung Transplantation (ISHLT) registry. Looking back 25 years, 4, 5 our current guidelines are more liberal perhaps because the referral pattern has changed, and we see potential recipients at later stages of heart failure. Still the basic concepts have not changed. As we put it in 1987, "Selection of patients who are 'too sick' for cardiac transplantation is a disservice to the patient and may waste a donor heart. Similarly, selection of patients who are not sick enough may result in the premature death of a 'successful' recipient. The current selection process, a combination of empirically derived contraindications with limited natural history data and considerable commonsense, is a complex but absolutely necessary part of modern heart transplantation." We did, in 1987, include the following relative contraindications to transplantation: age >50 years, pulmonary vascular resistance >6 to 8 Wood units, irreversible renal and hepatic dysfunction, active infection, any systemic life-limiting disease, inability to comply with therapy, history of a recent unresolved pulmonary embolus, severe peripheral or cerebrovascular disease, acute peptic ulcer, and absence of adequate psychosocial support. Notably absent were previous sternotomies, serum albumin level, and retransplantation. With regard to age criteria in our own program, we concluded from a subsequent study: "…that a rigidly defined age criterion for cardiac transplant recipients is not acceptable. Each potential recipient must be evaluated in terms of individual risk and benefit from the procedure." 6 With respect to donors, older donors and prolonged ischemic time were risks.
With our most recent ISHLT registry data, 7 donor characteristics influence 1-year posttransplant survival age and ischemic time (Table 1) .
Also, from the registry, recipient age was also found to be associated with poor outcome. And when recipient age reaches 70 years, the ISHLT registry has found a 1.75-fold increase in mortality. The registry has also found several other recipient factors that increase risk ( Table 2) .
For a surgeon who has great respect for the data from the authors and has used their cardio-pulmonary exercise selection criteria for years, I am enthusiastic about looking prospectively at the CARRS score. I think it will definitely help us come to a consensus on some difficult patients who should not be transplanted but tend to be selected for humanitarian reasons. However, I am concerned that too much emphasis on such a scoring system might eliminate some good candidates from being chosen. Adding a CARRS score to the evaluation checklist and considering it as another important selection criterion seem reasonable. In the end, looking at the whole patient and emphasis of our standard guidelines, including data from the registry, and applying them as fairly and sensibly as we can is still the foundation of potential recipient selection. 
